Laryngeal chemodenervation: Effects of injection site, dose, and volume

Annals of Otology, Rhinology and Laryngology

Volumn 108, Issue 12, 1999, Pages 1140-1145

  Lee, Patty ^a,b   Paniello, Randal C ^a,c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

^c Box 8115 ^*  (United States)

Author keywords

Botulinum toxin; Laryngeal adductory pressure; Laryngeal chemodenervation; Spasmodic dysphonia; Vecuronium bromide

Indexed keywords

BOTULINUM TOXIN; NEUROMUSCULAR BLOCKING AGENT; VECURONIUM;

AIRWAY PRESSURE; ARTICLE; CONTROLLED STUDY; DENERVATION; DOG; DOSE RESPONSE; DYSPHONIA; FEMALE; INTRAMUSCULAR DRUG ADMINISTRATION; LARYNX; NEUROMUSCULAR BLOCKING; NONHUMAN; PRIORITY JOURNAL; VOCAL CORD;

EID: 0032805758     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348949910801208     Document Type: Article

References (14)

1. Blitzer A, Brin MF, Fahn S, Lovelace RE. Localized injections of botulinum toxin for the treatment of focal laryngeal dystonia. Laryngoscope 1988;98:193-7.
2. Blitzer A, Brin MF. Laryngeal dystonia: a series with botulinum toxin therapy. Ann Otol Rhinol Laryngol 1991;100: 85-9.
3. Eleopra R, Tugnoli V, Caniatti L, DeGrandis D. Botulinum toxin treatment in the facial muscles of humans: evidence of an action in untreated near muscles by peripheral local diffusion. Neurology 1996;46:1158-60.
4. Ross MH, Charness ME, Sudarsky L, Logigian EL. Treatment of occupational cramp with botulinum toxin: diffusion of toxin to adjacent noninjected muscles. Muscle Nerve 1997;20: 593-8.
5. Buchman AS, Cornelia CL, Stebbins GT, Tanner CM, Goetz CG. Quantitative electromyographic analysis of changes in muscle activity following botulinum toxin therapy for cervical dystonia. Clin Neuropharmacol 1993;16:205-10.
6. Borodic GE. Joseph M, Fay L, Cozzolino D, Ferrante RJ. Botulinum A toxin for the treatment of spasmodic torticollis: dysphagia and regional toxin spread. Head Neck 1990; 12: 392-9.
7. Kobayashi T, Niimi S, Kumada M, Kosaki H, Hirose H. Botulinum toxin treatment for spasmodic dysphonia. Acta Otolaryngol Suppl (Stockh) 1993(suppl 504): 155-7.
8. George EF, Zimbler M, Wu B-L, Biller HF, Sanders I. Quantitative mapping of the effect of botulinum toxin injections in the thyroarytenoid muscle. Ann Otol Rhinol Laryngol 1992;101:888-92.
9. Shaari CM, George E, Wu BL, Biller HF, Sanders I. Quantifying the spread of botulinum toxin through muscle fascia. Laryngoscope 1991;101:960-4.
10. Borodic GE, Ferrante R, Pearce LB, Smith K. Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum A toxin injections. Mov Disord 1994;9:31-9.
11. Berke GS, Moore DM, Hantke DR, Hanson DG, Gerratt BR, Burstein F. Laryngeal modeling: theoretical, in vitro, in vivo. Laryngoscope 1987;97:871-81.
12. Paniello RC, Dahm JD. Long-term model of induced canine phonation. Otolaryngol Head Neck Surg 1998;118:512-22.
13. Dahm JD, Paniello RC. Tracheostomy for long-term laryngeal experimentation. Otolaryngol Head Neck Surg 1998; 118:376-80.
14. Paniello RC, Lee P. Pertracheal stimulation of the recurrent laryngeal nerve. Arch Otolaryngol Head Neck Surg (in press).